ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Osteoarthritis Medications Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-28E5704
Home | Market Reports | Health| Health Conditions| Arthritis
Global Osteoarthritis Medications Market Insights Forecast to 2028
BUY CHAPTERS

Global Osteoarthritis Medications Market Research Report 2025

Code: QYRE-Auto-28E5704
Report
July 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Johnson & Johnson
GlaxoSmithKline PLC
Novartis
Bayer
Eli Lilly
Sanofi
Horizon Pharma
Abbott
Mylan NV
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Flexion Therapeutics
Anika Therapeutics

Osteoarthritis Medications Market Size

The global market for Osteoarthritis Medications was valued at US$ 9883 million in the year 2024 and is projected to reach a revised size of US$ 12450 million by 2031, growing at a CAGR of 3.4% during the forecast period.

Osteoarthritis Medications Market

Osteoarthritis Medications Market

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Osteoarthritis Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteoarthritis Medications.
The Osteoarthritis Medications market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Osteoarthritis Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Osteoarthritis Medications companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Osteoarthritis Medications Market Report

Report Metric Details
Report Name Osteoarthritis Medications Market
Accounted market size in year US$ 9883 million
Forecasted market size in 2031 US$ 12450 million
CAGR 3.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, Eli Lilly, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma, Flexion Therapeutics, Anika Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Osteoarthritis Medications company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Osteoarthritis Medications Market growing?

Ans: The Osteoarthritis Medications Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the Osteoarthritis Medications Market size in 2031?

Ans: The Osteoarthritis Medications Market size in 2031 will be US$ 12450 million.

Who are the main players in the Osteoarthritis Medications Market report?

Ans: The main players in the Osteoarthritis Medications Market are Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, Eli Lilly, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma, Flexion Therapeutics, Anika Therapeutics

What are the Application segmentation covered in the Osteoarthritis Medications Market report?

Ans: The Applications covered in the Osteoarthritis Medications Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Osteoarthritis Medications Market report?

Ans: The Types covered in the Osteoarthritis Medications Market report are NSAIDs, Corticosteroids, Hyaluronic Acid Injection, Others

Recommended Reports

Pain Management Drugs

Musculoskeletal Diseases

Pain Relief Products

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Osteoarthritis Medications Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NSAIDs
1.2.3 Corticosteroids
1.2.4 Hyaluronic Acid Injection
1.2.5 Others
1.3 Market by Application
1.3.1 Global Osteoarthritis Medications Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Osteoarthritis Medications Market Perspective (2020-2031)
2.2 Global Osteoarthritis Medications Growth Trends by Region
2.2.1 Global Osteoarthritis Medications Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Osteoarthritis Medications Historic Market Size by Region (2020-2025)
2.2.3 Osteoarthritis Medications Forecasted Market Size by Region (2026-2031)
2.3 Osteoarthritis Medications Market Dynamics
2.3.1 Osteoarthritis Medications Industry Trends
2.3.2 Osteoarthritis Medications Market Drivers
2.3.3 Osteoarthritis Medications Market Challenges
2.3.4 Osteoarthritis Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Osteoarthritis Medications Players by Revenue
3.1.1 Global Top Osteoarthritis Medications Players by Revenue (2020-2025)
3.1.2 Global Osteoarthritis Medications Revenue Market Share by Players (2020-2025)
3.2 Global Osteoarthritis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Osteoarthritis Medications Revenue
3.4 Global Osteoarthritis Medications Market Concentration Ratio
3.4.1 Global Osteoarthritis Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Osteoarthritis Medications Revenue in 2024
3.5 Global Key Players of Osteoarthritis Medications Head office and Area Served
3.6 Global Key Players of Osteoarthritis Medications, Product and Application
3.7 Global Key Players of Osteoarthritis Medications, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Osteoarthritis Medications Breakdown Data by Type
4.1 Global Osteoarthritis Medications Historic Market Size by Type (2020-2025)
4.2 Global Osteoarthritis Medications Forecasted Market Size by Type (2026-2031)
5 Osteoarthritis Medications Breakdown Data by Application
5.1 Global Osteoarthritis Medications Historic Market Size by Application (2020-2025)
5.2 Global Osteoarthritis Medications Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Osteoarthritis Medications Market Size (2020-2031)
6.2 North America Osteoarthritis Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Osteoarthritis Medications Market Size by Country (2020-2025)
6.4 North America Osteoarthritis Medications Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Osteoarthritis Medications Market Size (2020-2031)
7.2 Europe Osteoarthritis Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Osteoarthritis Medications Market Size by Country (2020-2025)
7.4 Europe Osteoarthritis Medications Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Osteoarthritis Medications Market Size (2020-2031)
8.2 Asia-Pacific Osteoarthritis Medications Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Osteoarthritis Medications Market Size by Region (2020-2025)
8.4 Asia-Pacific Osteoarthritis Medications Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Osteoarthritis Medications Market Size (2020-2031)
9.2 Latin America Osteoarthritis Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Osteoarthritis Medications Market Size by Country (2020-2025)
9.4 Latin America Osteoarthritis Medications Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Osteoarthritis Medications Market Size (2020-2031)
10.2 Middle East & Africa Osteoarthritis Medications Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Osteoarthritis Medications Market Size by Country (2020-2025)
10.4 Middle East & Africa Osteoarthritis Medications Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Osteoarthritis Medications Introduction
11.1.4 Pfizer Revenue in Osteoarthritis Medications Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Osteoarthritis Medications Introduction
11.2.4 Johnson & Johnson Revenue in Osteoarthritis Medications Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Osteoarthritis Medications Introduction
11.3.4 GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2020-2025)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Osteoarthritis Medications Introduction
11.4.4 Novartis Revenue in Osteoarthritis Medications Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Osteoarthritis Medications Introduction
11.5.4 Bayer Revenue in Osteoarthritis Medications Business (2020-2025)
11.5.5 Bayer Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Osteoarthritis Medications Introduction
11.6.4 Eli Lilly Revenue in Osteoarthritis Medications Business (2020-2025)
11.6.5 Eli Lilly Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Osteoarthritis Medications Introduction
11.7.4 Sanofi Revenue in Osteoarthritis Medications Business (2020-2025)
11.7.5 Sanofi Recent Development
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Details
11.8.2 Horizon Pharma Business Overview
11.8.3 Horizon Pharma Osteoarthritis Medications Introduction
11.8.4 Horizon Pharma Revenue in Osteoarthritis Medications Business (2020-2025)
11.8.5 Horizon Pharma Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Osteoarthritis Medications Introduction
11.9.4 Abbott Revenue in Osteoarthritis Medications Business (2020-2025)
11.9.5 Abbott Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Osteoarthritis Medications Introduction
11.10.4 Mylan Revenue in Osteoarthritis Medications Business (2020-2025)
11.10.5 Mylan Recent Development
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Details
11.11.2 Daiichi Sankyo Business Overview
11.11.3 Daiichi Sankyo Osteoarthritis Medications Introduction
11.11.4 Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2020-2025)
11.11.5 Daiichi Sankyo Recent Development
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Osteoarthritis Medications Introduction
11.12.4 TEVA Revenue in Osteoarthritis Medications Business (2020-2025)
11.12.5 TEVA Recent Development
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Details
11.13.2 Almatica Pharma Business Overview
11.13.3 Almatica Pharma Osteoarthritis Medications Introduction
11.13.4 Almatica Pharma Revenue in Osteoarthritis Medications Business (2020-2025)
11.13.5 Almatica Pharma Recent Development
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Details
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Osteoarthritis Medications Introduction
11.14.4 Astellas Pharma Revenue in Osteoarthritis Medications Business (2020-2025)
11.14.5 Astellas Pharma Recent Development
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Details
11.15.2 Tide Pharmaceutical Business Overview
11.15.3 Tide Pharmaceutical Osteoarthritis Medications Introduction
11.15.4 Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2020-2025)
11.15.5 Tide Pharmaceutical Recent Development
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Details
11.16.2 Iroko Pharmaceuticals Business Overview
11.16.3 Iroko Pharmaceuticals Osteoarthritis Medications Introduction
11.16.4 Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2020-2025)
11.16.5 Iroko Pharmaceuticals Recent Development
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Details
11.17.2 Hengrui Pharmaceutical Business Overview
11.17.3 Hengrui Pharmaceutical Osteoarthritis Medications Introduction
11.17.4 Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2020-2025)
11.17.5 Hengrui Pharmaceutical Recent Development
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Details
11.18.2 Abiogen Pharma Business Overview
11.18.3 Abiogen Pharma Osteoarthritis Medications Introduction
11.18.4 Abiogen Pharma Revenue in Osteoarthritis Medications Business (2020-2025)
11.18.5 Abiogen Pharma Recent Development
11.19 Flexion Therapeutics
11.19.1 Flexion Therapeutics Company Details
11.19.2 Flexion Therapeutics Business Overview
11.19.3 Flexion Therapeutics Osteoarthritis Medications Introduction
11.19.4 Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2020-2025)
11.19.5 Flexion Therapeutics Recent Development
11.20 Anika Therapeutics
11.20.1 Anika Therapeutics Company Details
11.20.2 Anika Therapeutics Business Overview
11.20.3 Anika Therapeutics Osteoarthritis Medications Introduction
11.20.4 Anika Therapeutics Revenue in Osteoarthritis Medications Business (2020-2025)
11.20.5 Anika Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Johnson & Johnson
GlaxoSmithKline PLC
Novartis
Bayer
Eli Lilly
Sanofi
Horizon Pharma
Abbott
Mylan NV
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Flexion Therapeutics
Anika Therapeutics
List of Tables
 Table 1. Global Osteoarthritis Medications Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of NSAIDs
 Table 3. Key Players of Corticosteroids
 Table 4. Key Players of Hyaluronic Acid Injection
 Table 5. Key Players of Others
 Table 6. Global Osteoarthritis Medications Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Osteoarthritis Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Osteoarthritis Medications Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Osteoarthritis Medications Market Share by Region (2020-2025)
 Table 10. Global Osteoarthritis Medications Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Osteoarthritis Medications Market Share by Region (2026-2031)
 Table 12. Osteoarthritis Medications Market Trends
 Table 13. Osteoarthritis Medications Market Drivers
 Table 14. Osteoarthritis Medications Market Challenges
 Table 15. Osteoarthritis Medications Market Restraints
 Table 16. Global Osteoarthritis Medications Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Osteoarthritis Medications Market Share by Players (2020-2025)
 Table 18. Global Top Osteoarthritis Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2024)
 Table 19. Ranking of Global Top Osteoarthritis Medications Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Osteoarthritis Medications Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Osteoarthritis Medications, Headquarters and Area Served
 Table 22. Global Key Players of Osteoarthritis Medications, Product and Application
 Table 23. Global Key Players of Osteoarthritis Medications, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Osteoarthritis Medications Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Osteoarthritis Medications Revenue Market Share by Type (2020-2025)
 Table 27. Global Osteoarthritis Medications Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Osteoarthritis Medications Revenue Market Share by Type (2026-2031)
 Table 29. Global Osteoarthritis Medications Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Osteoarthritis Medications Revenue Market Share by Application (2020-2025)
 Table 31. Global Osteoarthritis Medications Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Osteoarthritis Medications Revenue Market Share by Application (2026-2031)
 Table 33. North America Osteoarthritis Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Osteoarthritis Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Osteoarthritis Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Osteoarthritis Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Osteoarthritis Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Osteoarthritis Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Osteoarthritis Medications Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Osteoarthritis Medications Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Osteoarthritis Medications Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Osteoarthritis Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Osteoarthritis Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Osteoarthritis Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Osteoarthritis Medications Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Osteoarthritis Medications Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Osteoarthritis Medications Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Pfizer Company Details
 Table 49. Pfizer Business Overview
 Table 50. Pfizer Osteoarthritis Medications Product
 Table 51. Pfizer Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 52. Pfizer Recent Development
 Table 53. Johnson & Johnson Company Details
 Table 54. Johnson & Johnson Business Overview
 Table 55. Johnson & Johnson Osteoarthritis Medications Product
 Table 56. Johnson & Johnson Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 57. Johnson & Johnson Recent Development
 Table 58. GlaxoSmithKline Company Details
 Table 59. GlaxoSmithKline Business Overview
 Table 60. GlaxoSmithKline Osteoarthritis Medications Product
 Table 61. GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 62. GlaxoSmithKline Recent Development
 Table 63. Novartis Company Details
 Table 64. Novartis Business Overview
 Table 65. Novartis Osteoarthritis Medications Product
 Table 66. Novartis Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 67. Novartis Recent Development
 Table 68. Bayer Company Details
 Table 69. Bayer Business Overview
 Table 70. Bayer Osteoarthritis Medications Product
 Table 71. Bayer Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 72. Bayer Recent Development
 Table 73. Eli Lilly Company Details
 Table 74. Eli Lilly Business Overview
 Table 75. Eli Lilly Osteoarthritis Medications Product
 Table 76. Eli Lilly Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 77. Eli Lilly Recent Development
 Table 78. Sanofi Company Details
 Table 79. Sanofi Business Overview
 Table 80. Sanofi Osteoarthritis Medications Product
 Table 81. Sanofi Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 82. Sanofi Recent Development
 Table 83. Horizon Pharma Company Details
 Table 84. Horizon Pharma Business Overview
 Table 85. Horizon Pharma Osteoarthritis Medications Product
 Table 86. Horizon Pharma Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 87. Horizon Pharma Recent Development
 Table 88. Abbott Company Details
 Table 89. Abbott Business Overview
 Table 90. Abbott Osteoarthritis Medications Product
 Table 91. Abbott Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 92. Abbott Recent Development
 Table 93. Mylan Company Details
 Table 94. Mylan Business Overview
 Table 95. Mylan Osteoarthritis Medications Product
 Table 96. Mylan Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 97. Mylan Recent Development
 Table 98. Daiichi Sankyo Company Details
 Table 99. Daiichi Sankyo Business Overview
 Table 100. Daiichi Sankyo Osteoarthritis Medications Product
 Table 101. Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 102. Daiichi Sankyo Recent Development
 Table 103. TEVA Company Details
 Table 104. TEVA Business Overview
 Table 105. TEVA Osteoarthritis Medications Product
 Table 106. TEVA Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 107. TEVA Recent Development
 Table 108. Almatica Pharma Company Details
 Table 109. Almatica Pharma Business Overview
 Table 110. Almatica Pharma Osteoarthritis Medications Product
 Table 111. Almatica Pharma Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 112. Almatica Pharma Recent Development
 Table 113. Astellas Pharma Company Details
 Table 114. Astellas Pharma Business Overview
 Table 115. Astellas Pharma Osteoarthritis Medications Product
 Table 116. Astellas Pharma Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 117. Astellas Pharma Recent Development
 Table 118. Tide Pharmaceutical Company Details
 Table 119. Tide Pharmaceutical Business Overview
 Table 120. Tide Pharmaceutical Osteoarthritis Medications Product
 Table 121. Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 122. Tide Pharmaceutical Recent Development
 Table 123. Iroko Pharmaceuticals Company Details
 Table 124. Iroko Pharmaceuticals Business Overview
 Table 125. Iroko Pharmaceuticals Osteoarthritis Medications Product
 Table 126. Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 127. Iroko Pharmaceuticals Recent Development
 Table 128. Hengrui Pharmaceutical Company Details
 Table 129. Hengrui Pharmaceutical Business Overview
 Table 130. Hengrui Pharmaceutical Osteoarthritis Medications Product
 Table 131. Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 132. Hengrui Pharmaceutical Recent Development
 Table 133. Abiogen Pharma Company Details
 Table 134. Abiogen Pharma Business Overview
 Table 135. Abiogen Pharma Osteoarthritis Medications Product
 Table 136. Abiogen Pharma Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 137. Abiogen Pharma Recent Development
 Table 138. Flexion Therapeutics Company Details
 Table 139. Flexion Therapeutics Business Overview
 Table 140. Flexion Therapeutics Osteoarthritis Medications Product
 Table 141. Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 142. Flexion Therapeutics Recent Development
 Table 143. Anika Therapeutics Company Details
 Table 144. Anika Therapeutics Business Overview
 Table 145. Anika Therapeutics Osteoarthritis Medications Product
 Table 146. Anika Therapeutics Revenue in Osteoarthritis Medications Business (2020-2025) & (US$ Million)
 Table 147. Anika Therapeutics Recent Development
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Osteoarthritis Medications Picture
 Figure 2. Global Osteoarthritis Medications Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Osteoarthritis Medications Market Share by Type: 2024 VS 2031
 Figure 4. NSAIDs Features
 Figure 5. Corticosteroids Features
 Figure 6. Hyaluronic Acid Injection Features
 Figure 7. Others Features
 Figure 8. Global Osteoarthritis Medications Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Osteoarthritis Medications Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Pharmacies Case Studies
 Figure 11. Retail Pharmacies Case Studies
 Figure 12. Online Pharmacies Case Studies
 Figure 13. Osteoarthritis Medications Report Years Considered
 Figure 14. Global Osteoarthritis Medications Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Osteoarthritis Medications Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Osteoarthritis Medications Market Share by Region: 2024 VS 2031
 Figure 17. Global Osteoarthritis Medications Market Share by Players in 2024
 Figure 18. Global Top Osteoarthritis Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Osteoarthritis Medications Revenue in 2024
 Figure 20. North America Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Osteoarthritis Medications Market Share by Country (2020-2031)
 Figure 22. United States Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Osteoarthritis Medications Market Share by Country (2020-2031)
 Figure 26. Germany Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Osteoarthritis Medications Market Share by Region (2020-2031)
 Figure 34. China Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Osteoarthritis Medications Market Share by Country (2020-2031)
 Figure 42. Mexico Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Osteoarthritis Medications Market Share by Country (2020-2031)
 Figure 46. Turkey Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Osteoarthritis Medications Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Pfizer Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 50. Johnson & Johnson Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 51. GlaxoSmithKline Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 52. Novartis Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 53. Bayer Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 54. Eli Lilly Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 55. Sanofi Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 56. Horizon Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 57. Abbott Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 58. Mylan Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 59. Daiichi Sankyo Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 60. TEVA Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 61. Almatica Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 62. Astellas Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 63. Tide Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 64. Iroko Pharmaceuticals Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 65. Hengrui Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 66. Abiogen Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 67. Flexion Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 68. Anika Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Osteoarthritis Drugs Market
Global Osteoarthritis Pain Drugs Market Insights Forecast to 2030
Global Drugs for Osteoarthritis Pain Market Insights Forecast to 2030
Medicine for Osteoarthritis Pain Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Osteoarthritis Therapeutics Market Research Report 2024
Hip Osteoarthritis Pain Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Spine Osteoarthritis Pain Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hip Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Osteoarthritis Pain Solution Market Research Report 2024
Spine Osteoarthritis Pain Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Painkiller Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Osteoarthritis Pain Market
Knee Osteoarthritis Treatment Market
Global Drugs for Pain Management Market Insights Forecast to 2030
Global OTC Pain Medications Market Research Report 2024
Global Pain Treatment Medication Market Research Report 2025
Joint Pain Relief Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Pain Management Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Arthritis Pain Injection Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Osteoarthritis Pain Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20Y6853
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Regenerative Therapies for Osteoarthritis Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36Y13907
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Rheumatoid Arthritis Diagnosis Tests Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19O6132
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Psoriatic Arthritis Therapeutics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9A6304
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions